Sucampo Pharmaceuticals Inc (SCMP) financial statements (2021 and earlier)

Company profile

Business Address 805 KING FARM BOULEVARD, SUITE 550
ROCKVILLE, MD 20850
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7585243198128128130
Cash and cash equivalents7585243198128128130
Restricted cash and investments 000252727
Receivables56403969413733
Inventory, net of allowances, customer advances and progress billings24232323242224
Inventory24232323242224
Deferred costs   0111
Other undisclosed current assets35171716172313
Total current assets:190165322307237238228
Noncurrent Assets
Property, plant and equipment6666767
Long-term investments and receivables11665555
Long-term investments11665   
Accounts and financing receivable, after allowance for credit loss    555
Intangible assets, net (including goodwill), including:108188194201208218206
Goodwill73737373737266
Intangible assets, net (excluding goodwill)108115121128135147140
Other undisclosed intangible assets, net (including goodwill)(73)      
Deferred costs   0   
Other noncurrent assets1111111
Other undisclosed noncurrent assets73   111
Total noncurrent assets:198200207214222232220
TOTAL ASSETS:388365529521460470448
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities31283129392622
Accounts payable61189865
Accrued liabilities12121712141314
Taxes payable104371763
Interest and dividends payable303    
Debt    222228
Deferred revenue and credits0011   
Other liabilities6432547
Other undisclosed current liabilities    145
Total current liabilities:37323532675662
Noncurrent Liabilities
Long-term debt and lease obligation   291197202208
Long-term debt, excluding current maturities   291197202208
Liabilities, other than long-term debt19152931518877
Deferred revenue and credits3321111
Deferred tax liabilities, net731821426959
Other liabilities999981817
Other undisclosed noncurrent liabilities292291291    
Total noncurrent liabilities:311307320321248290285
Total liabilities:349339355354315346347
Stockholders' equity
Stockholders' equity attributable to parent, including:4026174167145124101
Treasury stock, value(4)(4)(46)(46)(46)(46)46
Additional paid in capital130127124120113105102
Accumulated other comprehensive income54545455545029
Retained earnings (accumulated deficit)(141)(152)4238231516
Other undisclosed stockholders' equity attributable to parent000000(92)
Total stockholders' equity:4026174167145124101
TOTAL LIABILITIES AND EQUITY:388365529521460470448

Income statement (P&L) ($ in millions)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
Revenues61605673585247
Revenue, net59555370554944
Cost of revenue(17)(204)(17)(24)(16)(20)(23)
Cost of goods and services sold(17)(17)(17) (16)(20)(23)
Gross profit:44(144)3949423224
Operating expenses(23)(32)(29)(16)(29)(24)(24)
Operating income (loss):21(176)1133138(1)
Nonoperating income (expense)(4)(3)(3)(27)2(9)(7)
Other nonoperating income (expense)(1)(0)0(7)8(3)(0)
Interest and debt expense(3)(3)(3)4(6)(6)(6)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes333(4)666
Income (loss) from continuing operations before income taxes:18(179)8716(1)(7)
Income tax expense (benefit)(7)(2)(4)8(7)03
Net income (loss):10(181)5158(1)(4)
Other undisclosed net income attributable to parent   0   
Net income (loss) available to common stockholders, basic:10(181)5158(1)(4)
Interest on convertible debt1 1    
Other undisclosed net income available to common stockholders, diluted   0   
Net income (loss) available to common stockholders, diluted:12(181)6158(1)(4)

Comprehensive Income ($ in millions)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
Net income (loss):10(181)5158(1)(4)
Comprehensive income (loss):10(181)5158(1)(4)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)(0)052116
Comprehensive income (loss), net of tax, attributable to parent:10(181)515132011

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: